Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).

Viviani L, Harrison MJ, Zolin A, Haworth CS, Floto RA.

J Cyst Fibros. 2016 Sep;15(5):619-23. doi: 10.1016/j.jcf.2016.03.002.

2.

The vaccines consistency approach project: an EPAA initiative.

De Mattia F, Hendriksen C, Buchheit KH, Chapsal JM, Halder M, Lambrigts D, Redhead K, Rommel E, Scharton-Kersten T, Sesardic T, Viviani L, Ragan I.

Pharmeur Bio Sci Notes. 2015;2015:30-56.

PMID:
26830158
3.

Estimating the Incidence of Acute Infectious Intestinal Disease in the Community in the UK: A Retrospective Telephone Survey.

Viviani L, van der Es M, Irvine L, Tam CC, Rodrigues LC, Jackson KA, O'Brien SJ, Hunter PR; IID2 Study Executive Committee..

PLoS One. 2016 Jan 25;11(1):e0146171. doi: 10.1371/journal.pone.0146171.

4.

Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis.

Elborn JS, Bell SC, Madge SL, Burgel PR, Castellani C, Conway S, De Rijcke K, Dembski B, Drevinek P, Heijerman HG, Innes JA, Lindblad A, Marshall B, Olesen HV, Reimann AL, Solé A, Viviani L, Wagner TO, Welte T, Blasi F.

Eur Respir J. 2016 Feb;47(2):420-8. doi: 10.1183/13993003.00592-2015.

PMID:
26453627
5.

Future trends in cystic fibrosis demography in 34 European countries.

Burgel PR, Bellis G, Olesen HV, Viviani L, Zolin A, Blasi F, Elborn JS; ERS/ECFS Task Force on Provision of Care for Adults with Cystic Fibrosis in Europe..

Eur Respir J. 2015 Jul;46(1):133-41. doi: 10.1183/09031936.00196314.

6.

The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry.

Viviani L, Zolin A, Mehta A, Olesen HV.

Orphanet J Rare Dis. 2014 Jun 7;9:81. doi: 10.1186/1750-1172-9-81.

7.

European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis.

Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C.

J Cyst Fibros. 2014 May;13 Suppl 1:S43-59. doi: 10.1016/j.jcf.2014.03.011. Review.

8.

The relative frequency of CFTR mutation classes in European patients with cystic fibrosis.

De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L.

J Cyst Fibros. 2014 Jul;13(4):403-9. doi: 10.1016/j.jcf.2013.12.003.

9.

The second study of infectious intestinal disease (IID2): increased rates of recurrent diarrhoea in individuals aged 65 years and above.

Tam CC, Viviani L, Rodrigues LC, O'Brien SJ.

BMC Public Health. 2013 Aug 9;13:739. doi: 10.1186/1471-2458-13-739.

10.

Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.

Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, Drevinek P, Gulmans V, Krivec U, Olesen H; ECFS Patient Registry Steering Group..

Eur Respir J. 2014 Jan;43(1):125-33. doi: 10.1183/09031936.00166412.

11.

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.

Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H; French CF Modifier Gene Study Investigators.; European CF Registry Working Group..

Orphanet J Rare Dis. 2012 Sep 7;7:64. doi: 10.1186/1750-1172-7-64.

12.

The doublesex homolog Dmrt5 is required for the development of the caudomedial cerebral cortex in mammals.

Saulnier A, Keruzore M, De Clercq S, Bar I, Moers V, Magnani D, Walcher T, Filippis C, Kricha S, Parlier D, Viviani L, Matson CK, Nakagawa Y, Theil T, Götz M, Mallamaci A, Marine JC, Zarkower D, Bellefroid EJ.

Cereb Cortex. 2013 Nov;23(11):2552-67. doi: 10.1093/cercor/bhs234.

13.

Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis.

Sorio C, Buffelli M, Angiari C, Ettorre M, Johansson J, Vezzalini M, Viviani L, Ricciardi M, Verzè G, Assael BM, Melotti P.

PLoS One. 2011;6(7):e22212. doi: 10.1371/journal.pone.0022212.

14.

Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis.

Viviani L, Assael BM, Kerem E; ECFS (A) H1N1 study group..

J Cyst Fibros. 2011 Sep;10(5):370-6. doi: 10.1016/j.jcf.2011.06.004.

15.

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice.

Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O'Brien SJ; IID2 Study Executive Committee..

Gut. 2012 Jan;61(1):69-77. doi: 10.1136/gut.2011.238386.

16.

Absence of a gender gap in survival. An analysis of the Italian registry for cystic fibrosis in the paediatric age.

Viviani L, Bossi A, Assael BM; Italian Registry for Cystic Fibrosis Collaborative Group..

J Cyst Fibros. 2011 Sep;10(5):313-7. doi: 10.1016/j.jcf.2011.03.007.

17.

Evaluation of a home telemonitoring service for adult patients with cystic fibrosis: a pilot study.

Grzincich G, Gagliardini R, Bossi A, Bella S, Cimino G, Cirilli N, Viviani L, Iacinti E, Quattrucci S.

J Telemed Telecare. 2010;16(7):359-62. doi: 10.1258/jtt.2010.091006.

PMID:
20643846
18.

Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis.

McCormick J, Mehta G, Olesen HV, Viviani L, Macek M Jr, Mehta A; European Registry Working Group..

Lancet. 2010 Mar 20;375(9719):1007-13. doi: 10.1016/S0140-6736(09)62161-9.

PMID:
20304245
19.

Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications.

Pazin-Filho A, Romano MM, Almeida-Filho OC, Furuta MS, Viviani LF, Schmidt A, Marin-Neto JA, Maciel BC.

Braz J Med Biol Res. 2006 Apr;39(4):483-7.

20.

[The Italian registry for cystic fibrosis: what has changed in the last decade].

Viviani L, Padoan R, Giglio L, Bossi A.

Epidemiol Prev. 2003 Mar-Apr;27(2):91-6. Italian.

PMID:
12848021
Items per page

Supplemental Content

Loading ...
Support Center